Benjamin Gannon

For 15 years, the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) has been the voice of small to mid-sized health technology companies in Europe. As a trade association, we advocate for sound public policy that supports innovation, while fostering a community built on a shared purpose: improving and saving the lives of European patients through innovative therapies and medical technology. EUCOPE’s members – who represent over 2600+ innovative companies directly or via associations – are researching, designing, developing, supplying, manufacturing, and deploying the next generation of pharmaceutical innovation and therapeutic solutions around the continent. Based in Brussels, Belgium, EUCOPE takes pride in providing expert insights into EU policies and legislation as well as market access, aiding our members in navigating the complex world of health technologies in Europe. EUCOPE’s network and trusted relationships with established stakeholders at the EU and national levels help our members connect and share experiences with the European Commission, the European Parliament, Member States’ representatives, patient organisations, healthcare professionals and payers, academics, and other industry associations. Our commitment is to lead and engage in partnerships spanning across the entire medicine lifecycle to find actionable solutions that benefit our members, the patients they serve, and healthcare systems overall. www.eucope.org

The Nanotechnology Industries Association (NIA) is the leading voice of the nanotechnology industries. On behalf of membership across Europe and around the world, we support the development of nanotech innovations that improve the lives of consumers, preserve our environment and advance our world. NIA and our Members are committed to the safe, sustainable and beneficial use of nanotechnology and nanomaterials across all industries. We believe in fostering a better understanding of nanotechnology’s important role in society and building a positive global environment for nanotech innovation.

For 15 years, the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) has been the voice of small to mid-sized health technology companies in Europe. As a trade association, we advocate for sound public policy that supports innovation, while fostering a community built on a shared purpose: improving and saving the lives of European patients through innovative therapies and medical technology. EUCOPE’s members – who represent over 2600+ innovative companies directly or via associations – are researching, designing, developing, supplying, manufacturing, and deploying the next generation of pharmaceutical innovation and therapeutic solutions around the continent. Based in Brussels, Belgium, EUCOPE takes pride in providing expert insights into EU policies and legislation as well as market access, aiding our members in navigating the complex world of health technologies in Europe. EUCOPE’s network and trusted relationships with established stakeholders at the EU and national levels help our members connect and share experiences with the European Commission, the European Parliament, Member States’ representatives, patient organisations, healthcare professionals and payers, academics, and other industry associations. Our commitment is to lead and engage in partnerships spanning across the entire medicine lifecycle to find actionable solutions that benefit our members, the patients they serve, and healthcare systems overall. www.eucope.org

The Nanotechnology Industries Association (NIA) is the leading voice of the nanotechnology industries. On behalf of membership across Europe and around the world, we support the development of nanotech innovations that improve the lives of consumers, preserve our environment and advance our world. NIA and our Members are committed to the safe, sustainable and beneficial use of nanotechnology and nanomaterials across all industries. We believe in fostering a better understanding of nanotechnology’s important role in society and building a positive global environment for nanotech innovation.